Gemelli Biotech is proud to partner closely with Cedars-Sinai in Los Angeles, ranked by US News and World Report as one of the top 10 hospitals in the nation. The Medically Associated Science and Technology (MAST) program at Cedars-Sinai is dedicated to the development of lab tests, drugs and devices to diagnose and treat patients.
Partnership with MAST allows Gemelli to operate on the cutting edge, with an early look at the newest scientific discoveries related to the microbiome and the ability to draw on MAST’s expertise in navigating the US Food and Drug Administration approval process.
Visit the Cedars-Sinai Website
Visit the MAST Website
INTERNATIONAL CLINICAL LABORATORIES
Gemelli Biotech partners with clinical laboratories around the world to make ibs-smart™ available internationally.
Our list of partnerships is growing consistently and ranges from Swizerland (Unilabs) to Mexico (Biomedica) to Japan (CA Nutrients).
To see a complete, current list of lab partnerships for ibs-smart™ visit the ibs-smart™ website